Gruthan Bioscience receives funding to develop a novel class of cholesterol-lowering drugs

Gruthan Bioscience was recently awarded funding to develop a novel class of cholesterol-lowering drugs to treat a rare form of familial hypercholesterolemia; It could one day be used to treat high cholesterol more widely

Read more